Abstract:Objective To explore the efficacy and safety of mild hypothermia (MH) in treating the infants with moderate-to-severe neonatal hypoxic-ischemic encephalopathy(HIE),and to make a follow-up of the nerve motor development of the infants at 18 months old after discharge.Methods Totally 61 neonates with moderate-to-severe HIE in Neonatal Intensive Care Unit (NICU) from Jan.2007 to Dec.2013 were retrospectively analyzed.According to before and after MH therapeutic apparatus was used by NICU of Shanghai Children's Hospital,61 neonates of HIE were divided into 2 groups,the conventional treatment group(25 cases) and MH treatment group(36 cases).The patients in both groups were measured respectively by using the amplitude integrated electroencephalography (aEEG) before MH treatment and at 72 hours after M H treatment,by neonatal behavioral neurological assessment(NBNA) on the 28th day after birth,and by adopting Bayley Scales of Infant Development at 18 months old.The adverse reactions,serious disability cases and deaths of MH treatment were recorded.Results Compared with the conventional treatment group,aEEG recording before treatment showed no statistically significant differences in MH treatment group [maximum voltage:(22.4 ±3.1) μV vs(18.6 ±2.5) μV,maximum voltage:(8.2 ±2.6)μV vs(6.5 ±1.9) μV,t =1.264,0.852,all P ＞ 0.05].However,aEEG recording at 72 h after treatment showed statistically significant differences in MH treatment group [maximum voltage:(24.1 ± 3.2) μV vs (30.6 ± 2.8) μV,maximum voltage:(9.7 ± 3.4) μV vs (13.3 ± 2.2) μV,t =6.376,4.257,all P ＜ 0.05].Severe disability cases [24.0％ (6/25 cases) vs 5.6％ (2/36 cases),x2 =4.405,P ＜ 0.05] and deaths [16.0％ (4/25 cases) vs 0 (0/36 case),x2 =6.1 64,P ＜ 0.05] in MH treatment group were significantly decreased,and there was significantly difference in NBNA on the 28th day after birth[(35.9 ± 2.1) vs(39.1-± 1.6),t =3.361,P ＜ 0.05],and scales of neurobehavioral evaluation through follow-up of 18 months old [mental development index (MDI):(85.2 ± 10.7) vs (96.5-± 13.1),t =7.839,P ＜ 0.05].Very few neonates had apnea,coagulation dysfunction,arrhythmia and other adverse reactions in MH treatment course.Conclusions MH treating moderate-to-severe HIE is safe and effective.MH is effective in reducing death and major disabilities in neonates with moderate-to-severe HIE and without significant side effects.MH can obviously improve the development of nervous system disorders in 0-18 months infants,and can significantly improve these infants' Bayley developmental scale neurobehavioral scores.

Effect of Hyperbaric Oxygen Combined with Ganglioside in Treatment of Neonatal Hypoxic Ischemic Encephalopathy

Meta-analysis Evaluation of the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Ganglioside

Effect of Ganglioside on Developmental Quotient and Developmental Disorders of Neonates with Hypoxic Ischemic Encephalopathy

The Curative Effect and Prognosis of Hyperbaric Oxygen on Neonatal Hypoxic Ischemic Encephalopathy

Meta - Analysis of Ganglioside Treatment for Hypoxic - Ischemic Encephalopathy in Newborn Infants

Observation of clinical curative effect of ganglioside for 42 neonate with hypoxic ischemic encephalopathy

Clinical Trial of Monosialotetrahexosyl Ganglioside Sodium Injection Combined with Citicoline in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

Neural Function Recovery and Safety of Mild Hypothermia Therapy Combined with Monosialotetrahexosylganglioside on Neonatal Asphyxia Complicated by Hypoxic Ischemic Encephalopathy

Clinical Observation of the Hyperbaric Oxygenation in the Treatment of Neonates with Hypoxic Ischemic Encephalopahy

Effect of Hyperbaric Oxygen with Tetramethylpyrazine on NSE and MBP in Newborns with Severe Hypoxic and Ischemic Encephalopathy

Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy.

The effect of cell growth peptide and high pressure oxygen in hypoxic ischemic encephalopathy

Protective effect of combined NGF and ganglioside GM_1 on hypoxic-ischemic brain injury of newborn rats

Effects of fructose-1,6-diphosphate combined with hyperbaric oxygenation on prognosis of severe neonatal hypoxic-ischemic encephalopathy

Is Erythropoietin Combining with Therapeutic Hypothermia an Efficient and Safe Therapy in Neonatal Hypoxic Ischemic Encephalopathy: A Prospective and Randomized Clinical Trial

Hyperbaric oxygen therapy in patients with hypoxic ischemic encephalopathy

Curative Effect Analysis of Mild Hypothermia in Treatment of Neonatal Hypoxic-Ischemic Encephalopathy and Follow-Up Study of 36 Children Aged 18 Months

Hypoxic ischemic encephalopathy (HIE)

Effects of human umbilical cord mesenchymal stem cells transplantation on treating hypoxic-ischemic encephalopathy

Effect of Hyperbaric Oxygen Combined with Ganglion Glycosides on Thrombin, Serum Myelin Basic Protein and D-dimer in Patients with Intracerebral Hemorrhage

[Efficacy of therapeutic hypothermia on mild neonatal hypoxic-ischemic encephalopathy: a prospective randomized controlled study]